4Q25 & FY25 Earnings Call J a n u a r y 3 0 , 2 0 2 6 Forward-looking Statements 1 Value-first commercial approach continues to preserve ECU values 2 Announced Braskem long-term agreement, upgrading our export EDC values 3 Successful Epoxy volume growth amid European capacity closures 4 Winchester reduced commercial production accelerating destocking 5 Generated $321M of operating cash flow, keeping net debt flat year-over-year Chlor Alkali Products & Vinyls Segment Performance This presentation includes fo ...

Core Insights - Olin Corporation reported a net loss of $85.7 million for Q4 2025, a significant decline from a net income of $10.7 million in Q4 2024, reflecting ongoing market challenges and operational disruptions [1][2] - The company's adjusted EBITDA for Q4 2025 was $67.7 million, down from $193.4 million in Q4 2024, indicating a substantial decrease in operational profitability [1][27] - Total sales for Q4 2025 were $1,665.1 million, slightly lower than $1,671.3 million in Q4 2024, showing a stable revenue stream despite adverse conditions [1][21] Financial Performance - The full year 2025 reported a net loss of $42.8 million, compared to a net income of $108.6 million in 2024, highlighting a year-over-year decline in profitability [1][21] - Operating cash flow for Q4 2025 was $321.2 million, demonstrating effective cash generation despite the net loss [2] - The company ended 2025 with net debt of approximately $2.7 billion, maintaining a net debt to adjusted EBITDA ratio of 4.1 times, indicating a stable leverage position [12][32] Segment Performance - Chlor Alkali Products and Vinyls segment reported sales of $856.4 million in Q4 2025, down from $953.7 million in Q4 2024, primarily due to lower pricing [6][7] - The Epoxy segment saw sales increase to $359.3 million in Q4 2025 from $282.2 million in Q4 2024, driven by higher volumes, although it still reported a segment loss of $19.2 million [8] - Winchester segment sales were $449.4 million in Q4 2025, up from $435.4 million in Q4 2024, with military sales offsetting declines in commercial ammunition [9] Strategic Initiatives - The company is focused on its "Optimize the Core" strategic priorities, which include enhancing operational reliability and achieving structural cost reductions through the Beyond250 initiative, which has already realized $44 million in cost savings in 2025 [2][3] - Olin plans to close its epoxy resin manufacturing facility in Guarujá, Brazil, in Q1 2026, expecting to achieve annual structural cost savings of approximately $10 million [11] - The company anticipates that its Epoxy business will return to profitability in 2026, supported by new supply agreements and ongoing cost reduction efforts [3]

Published: January 2026 1 FISCAL 2026 Q3 INVESTOR PRESENTATION FORWARD-LOOKING STATEMENTS © 2026 Hawkins, Inc. The information contained in this presentation includes "forward-looking statements" which reflect management's expectations or beliefs as of the date of this presentation. Hawkins, Inc. cautions that actual future results could differ materially from the forward-looking statements in this presentation. Actual results may be affected by many important factors including risks and uncertainties ident ...

Core Insights - Warren Buffett will retire at age 95 after over 60 years of running Berkshire Hathaway, making a significant investment in OxyChem for $9.7 billion just before his departure [1][2] Group 1: Acquisition Details - Berkshire Hathaway is acquiring OxyChem, a petrochemicals business from Occidental Petroleum, marking its most significant acquisition since 2022 [2] - The acquisition price of $9.7 billion is considered a bargain, with OxyChem being valued at about eight times its projected 2025 EBITDA, especially in a weak chemical industry [3] - OxyChem is a stable cash generator producing essential products like chlorine, caustic soda, and PVC, which are crucial for various industries [4] Group 2: Financial Implications - The structure of the deal benefits both companies, with Occidental Petroleum receiving $9.7 billion in cash, planning to use $6.5 billion to reduce its debt below $15 billion, thus improving its balance sheet [5] - This debt reduction is expected to save Occidental $350 million to $400 million annually in interest payments, enhancing Berkshire's existing 28.2% ownership and providing additional protection against energy price volatility [5]

Core Viewpoint - Olin Corporation has revised its fourth quarter 2025 adjusted EBITDA outlook to approximately $67 million, significantly lower than the previous estimate of $110 to $130 million, primarily due to issues in the Chlor Alkali Products and Vinyls business [1][2]. Company Overview - Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products, including chlorine, caustic soda, vinyls, and various other chemicals, as well as a major U.S. manufacturer of ammunition [3]. Financial Performance - The adjusted EBITDA for the fourth quarter 2025 is now expected to be around $67 million, a decrease from the earlier forecast of $110 to $130 million [1]. - The earnings shortfall is attributed to an extended planned maintenance turnaround and unplanned downtime at the Freeport, Texas operations, along with lower-than-expected pipeline chlorine demand [1][2]. Operational Challenges - The Chlor Alkali Products and Vinyls segment faced a significant decline in chlorine demand and operational issues at the Freeport site, which included a planned turnaround and interruptions in raw material supply from a third party [2]. - The Freeport site has since returned to normal operations, but the impact of these challenges has affected the overall financial outlook [2].

Core Insights - Olin Corporation's shares have faced significant challenges, with a 48.69% decline over the past year, attributed to factors such as subsidized imports from Asia and Europe [4][9] - Teresa M. Vermillion, the VP & Treasurer, sold 4,500 shares through an option exercise, resulting in a 20.74% reduction in her direct ownership [7][9] - The company is focusing on its core chemical and ammunition segments, with a recent strategic partnership with Braskem aimed at enhancing growth in its vinyls business [10][11] Company Overview - Olin Corporation operates in the chemicals and ammunition sectors, generating revenue of $6.8 billion and a net income of $53.80 million [4][5] - The company has a dividend yield of 3.9% and has seen a 1-year price change of -48.69% [4] Transaction Details - The transaction involved the sale of shares at a weighted average price of approximately $20.86, with a total transaction value of around $93,850.20 [2][7] - Post-transaction, Vermillion holds 17,199 shares, valued at approximately $353,783.43 [2][7] Market Context - The company's stock performance has been negatively impacted by subdued global demand in the epoxy market and lower-than-expected ammunition sales [10] - The recent insider transaction is viewed as administrative rather than indicative of the company's future performance [7][9]

Core Insights - Warren Buffett will step down as CEO of Berkshire Hathaway on January 1, 2026, while remaining as chairman, with Greg Abel set to succeed him [1] - Buffett executed a $9.7 billion deal to acquire OxyChem from Occidental Petroleum shortly before the leadership transition [1][2] Company Background - Berkshire Hathaway has a long-standing relationship with Occidental Petroleum, having provided a $10 billion loan in 2019 for its acquisition of Anadarko Petroleum [4] - Berkshire has been increasing its stake in Occidental, currently owning 26.9% of the company, valued at approximately $11.7 billion [5][6] Acquisition Details - The $9.7 billion purchase price for OxyChem is significant compared to Occidental's market cap of $43.6 billion [6] - OxyChem is involved in producing chemicals for various applications, including chlorine and polyvinyl chloride, and plays a role in Occidental's carbon capture initiatives [7] Strategic Implications - The acquisition aligns with Berkshire Hathaway's investment strategy, focusing on underappreciated businesses rather than high-growth stocks [8] - The sale of OxyChem is not expected to hinder Occidental's low-carbon goals but indicates a shift towards projects that generate immediate free cash flow [9]

Core Insights - Berkshire Hathaway is acquiring Occidental Petroleum's chemical unit, OxyChem, for $9.7 billion in cash, marking its largest deal in three years just before Warren Buffett's retirement as CEO [1][9] - Berkshire has significantly increased its stake in Occidental Petroleum, reaching 32.7% by August 2025, making it the sixth-largest holding in its portfolio [2] - The acquisition focuses solely on OxyChem, a key manufacturer of chemicals, rather than full control of Occidental [3] Financial Performance - OxyChem generated $1.1 billion in operating income for the fiscal year ending December 31, 2024, contributing approximately 16% to Occidental's total income [6] - Occidental's capital expenditures for OxyChem are projected to rise by $200 million to $900 million in 2025, indicating a commitment to growth in this segment [6] Debt and Financial Strategy - The sale of OxyChem will provide Occidental with $6.5 billion to repay debt, enhancing its balance sheet and allowing for potential share repurchases and dividend growth [7] - Occidental's debt concerns have been exacerbated by its $12 billion acquisition of CrownRock in 2024, primarily financed through borrowing [7] Market Implications - The divestiture of OxyChem will position Occidental as a more focused oil and gas company, increasing its vulnerability to fluctuations in commodity prices [8]

Group 1 - Berkshire Hathaway is acquiring Occidental Petroleum's chemical division, OxyChem, for $9.7 billion, marking a significant transaction for the company [1] - The acquisition utilizes less than 3% of Berkshire's cash reserves, which exceed $344 billion, and is not expected to significantly impact the conglomerate's financial performance [5][4] - OxyChem produces various chemicals, including chlorine for water treatment and vinyl chloride for plastics, complementing Berkshire's existing portfolio, particularly Lubrizol [6] Group 2 - Warren Buffett's involvement in the deal is implied, despite his absence in the official announcement, indicating a potential transition of leadership to Vice Chair Greg Abel [2][3] - Analysts are observing how Abel's leadership style and deal-making approach may differ from Buffett's as he prepares to take over as CEO [7][8] - The market reaction to the acquisition was lukewarm, with Berkshire's shares slightly declining and Occidental's shares dropping over 7% following the announcement [5]

Core Insights - Berkshire Hathaway has agreed to acquire Occidental Petroleum's OxyChem segment for $9.7 billion, with the transaction expected to close in Q4 2025 [1][5]. Group 1: Acquisition Details - OxyChem produces standardized chemicals used in various applications, including water treatment, pharmaceuticals, and construction [2]. - The chemicals manufactured by OxyChem include chlorine, caustic soda, polyvinyl chloride, and ethylene [2]. - Occidental's other subsidiary will retain OxyChem's legacy environmental liabilities, while Glenn Springs Holdings will manage existing remedial projects [3]. Group 2: Strategic Implications - The acquisition enhances Occidental Petroleum's financial position, allowing the company to concentrate on its core oil and gas business and pursue further development and acquisitions [5]. - OxyChem has been recognized as a well-managed business with skilled employees, and there is confidence in its continued success under Berkshire Hathaway's ownership [6]. Group 3: Operational Footprint - OxyChem operates manufacturing plants at 21 domestic sites across various states in the U.S. and at two international locations in Canada and Chile [6].